| EGF-EGFR-RAS-ERK signaling pathway |
| Mutation-activated EGFR to RAS-ERK signaling pathway |
| EGFR-overexpression to RAS-ERK signaling pathway |
| ERBB2-overexpression to RAS-ERK signaling pathway |
| RET fusion kinase to RAS-ERK signaling pathway |
| EML4-ALK fusion kinase to RAS-ERK signaling pathway |
| Mutation-activated KRAS/NRAS to ERK signaling pathway |
| HGF-MET-RAS-ERK signaling pathway |
| Mutation-activated MET to RAS-ERK signaling pathway |
| EGF-EGFR-PLCG-ERK signaling pathway |
| Mutation-activated EGFR to PLCG-ERK signaling pathway |
| EML4-ALK fusion kinase to PLCG-ERK signaling pathway |
| EGF-EGFR-PI3K signaling pathway |
| Mutation-activated EGFR to PI3K signaling pathway |
| EML4-ALK fusion kinase to PI3K signaling pathway |
| Mutation-activated KRAS/NRAS to PI3K signaling pathway |
| HGF-MET-PI3K signaling pathway |
| Mutation-activated MET to PI3K signaling pathway |
| EGF-EGFR-RAS-RASSF1 signaling pathway |
| Loss of RASSF1 to RAS-RASSF1 signaling pathway |
| Cytokine-Jak-STAT signaling pathway |
| EML4-ALK fusion kinase to Jak-STAT signaling pathway |
| MDM2-p21-Cell cycle G1/S |
| Mutation-inactivated p16(INK4a) to p16-cell cycle G1/S |
| Mutation-inactivated TP53 to transcription |